Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Malfanti

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|January 26, 2022
Immunotherapy for glioblastoma: the promise of combination strategiesMathilde Bausart, Véronique Préat, Alessio Malfanti
ACS Nano|April 18, 2025
Stimuli-Responsive Nanomedicines for the Treatment of Non-cancer Related Inflammatory DiseasesJingjing Yang, Anne des Rieux, Alessio Malfanti
Advanced Drug Delivery Reviews|August 30, 2021
Rationally designed drug delivery systems for the local treatment of resected glioblastomaChiara Bastiancich, Alessio Malfanti, Véronique Préat, et al.
International Journal of Pharmaceutics: X|January 9, 2023
Synergistic effect of doxorubicin lauroyl hydrazone derivative delivered by α-tocopherol succinate micelles for the treatment of glioblastomaMingchao Wang, Alessio Malfanti, Chiara Bastiancich, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 28, 2025
Design Strategies for Hyaluronic Acid-based Drug Delivery Systems in Cancer ImmunotherapyGiulia Rodella, Véronique Préat, Bernard Gallez, et al.
Drug Delivery and Translational Research|April 11, 2023
Hyaluronic acid-antigens conjugates trigger potent immune response in both prophylactic and therapeutic immunization in a melanoma modelAlessio Malfanti, Mathilde Bausart, Kevin Vanvarenberg, et al.
Biomaterials|January 26, 2023
Combination of hyaluronic acid conjugates with immunogenic cell death inducer and CpG for glioblastoma local chemo-immunotherapy elicits an immune response and induces long-term survivalGiuseppina Catania, Giulia Rodella, Kevin Vanvarenberg, et al.
Drug Delivery and Translational Research|October 27, 2023
Local delivery of doxorubicin prodrug via lipid nanocapsule-based hydrogel for the treatment of glioblastomaMingchao Wang, Raphaël Bergès, Alessio Malfanti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 1, 2025
Nanoparticles loaded with a CSF1R antagonist selectively depletes microglial cells and modulates inflammation in spinal cord injuryJingjing Yang, Bernard Ucakar, Kevin Vanvarenberg, et al.
Pharmaceutics|January 21, 2022
Design of Bio-Responsive Hyaluronic Acid-Doxorubicin Conjugates for the Local Treatment of GlioblastomaAlessio Malfanti, Giuseppina Catania, Quentin Degros, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Journal of Experimental & Clinical Cancer Research : CR|January 26, 2022
Immunotherapy for glioblastoma: the promise of combination strategiesMathilde Bausart, Véronique Préat, Alessio Malfanti
ACS Nano|April 18, 2025
Stimuli-Responsive Nanomedicines for the Treatment of Non-cancer Related Inflammatory DiseasesJingjing Yang, Anne des Rieux, Alessio Malfanti
Advanced Drug Delivery Reviews|August 30, 2021
Rationally designed drug delivery systems for the local treatment of resected glioblastomaChiara Bastiancich, Alessio Malfanti, Véronique Préat, et al.
International Journal of Pharmaceutics: X|January 9, 2023
Synergistic effect of doxorubicin lauroyl hydrazone derivative delivered by α-tocopherol succinate micelles for the treatment of glioblastomaMingchao Wang, Alessio Malfanti, Chiara Bastiancich, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 28, 2025
Design Strategies for Hyaluronic Acid-based Drug Delivery Systems in Cancer ImmunotherapyGiulia Rodella, Véronique Préat, Bernard Gallez, et al.
Drug Delivery and Translational Research|April 11, 2023
Hyaluronic acid-antigens conjugates trigger potent immune response in both prophylactic and therapeutic immunization in a melanoma modelAlessio Malfanti, Mathilde Bausart, Kevin Vanvarenberg, et al.
Biomaterials|January 26, 2023
Combination of hyaluronic acid conjugates with immunogenic cell death inducer and CpG for glioblastoma local chemo-immunotherapy elicits an immune response and induces long-term survivalGiuseppina Catania, Giulia Rodella, Kevin Vanvarenberg, et al.
Drug Delivery and Translational Research|October 27, 2023
Local delivery of doxorubicin prodrug via lipid nanocapsule-based hydrogel for the treatment of glioblastomaMingchao Wang, Raphaël Bergès, Alessio Malfanti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 1, 2025
Nanoparticles loaded with a CSF1R antagonist selectively depletes microglial cells and modulates inflammation in spinal cord injuryJingjing Yang, Bernard Ucakar, Kevin Vanvarenberg, et al.
Pharmaceutics|January 21, 2022
Design of Bio-Responsive Hyaluronic Acid-Doxorubicin Conjugates for the Local Treatment of GlioblastomaAlessio Malfanti, Giuseppina Catania, Quentin Degros, et al.
Pageof 4